N-(2,6-Dimethylphenl)-2-Piperidine Carboxamide structure
|
Common Name | N-(2,6-Dimethylphenl)-2-Piperidine Carboxamide | ||
|---|---|---|---|---|
| CAS Number | 15883-20-2 | Molecular Weight | 232.321 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 392.3±42.0 °C at 760 mmHg | |
| Molecular Formula | C14H20N2O | Melting Point | 114-117ºC | |
| MSDS | Chinese USA | Flash Point | 149.0±28.0 °C | |
| Symbol |
GHS06 |
Signal Word | Danger | |
Use of N-(2,6-Dimethylphenl)-2-Piperidine CarboxamideDesbutylbupivacaine also known as N-Desbutyl Bupivacaine, it is a major metabolite of Bupivacaine. |
| Name | N-(2,6-Dimethylphenl)-2-Piperidine Carboxamide |
|---|---|
| Synonym | More Synonyms |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 392.3±42.0 °C at 760 mmHg |
| Melting Point | 114-117ºC |
| Molecular Formula | C14H20N2O |
| Molecular Weight | 232.321 |
| Flash Point | 149.0±28.0 °C |
| Exact Mass | 232.157562 |
| PSA | 41.13000 |
| LogP | 2.29 |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.567 |
| Storage condition | -20°C Freezer |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301 |
| Precautionary Statements | Missing Phrase - N15.00950417 |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | 25 |
| Safety Phrases | 45 |
| RIDADR | UN 2811 6.1 / PGIII |
| RTECS | TM6076000 |
| HS Code | 2933399090 |
| Precursor 8 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Kinetics of bupivacaine after clonidine pretreatment in mice.
Can. J. Anaesth. 42(5 Pt 1) , 434-7, (1995) Previous studies have reported that clonidine pretreatment causes an increase in the local anaesthetic activity of bupivacaine. This study was designed to document possible changes in the pharmacokine... |
|
|
Population pharmacokinetic analysis of ropivacaine and its metabolite 2',6'-pipecoloxylidide from pooled data in neonates, infants, and children.
Br. J. Anaesth. 107(3) , 409-24, (2011) The aim was to characterize ropivacaine and 2',6'-pipecoloxylidide (PPX) pharmacokinetics and factors affecting them in paediatric anaesthesia.Population pharmacokinetics of ropivacaine and its active... |
|
|
Bupivacaine kinetics during hyperthermia in rats.
Can. J. Anaesth. 41(3) , 253-6, (1994) The aim of this study was to document possible alterations of bupivacaine pharmacokinetic behaviour in rats during hyperthermia. Two groups of Wistar AF IO PS male rats (Group A = normothermic control... |
| N-(2',6'- Dinethylphenyl)-2-piperidinecarboxamide HCL |
| UNII:NF8RN1V7VM |
| Mepivacaine impurity B |
| Desbutylbupivacaine |
| (RS)-N-(2,6-Dimethylphenyl)piperidine-2-carboxamide,Desbutylbupivacaine |
| N-(2,6-Dimethylphenyl)-2-piperidinecarboxamide |
| N-Desbutyl Bupivacaine |
| MFCD08458869 |
| 2',6'-Pipecoloxylidide |
| 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)- |
| N-(2,6-Dimethylphenyl)piperidine-2-carboxamide |
| N-(2',6'-Dimethylphenyl)-2-piperidinecarboxamide |
| (RS)-N-(2,6-Dimethylphenyl)piperidine-2-carboxamide |
| N-(2,6-DIMETHYLPHENYL ) -PIPERIDINE-2-CARBOXYLIC AMIDE |
| Bupivacaine Impurity 4 |